IDEXX Laboratories, Inc. (IDXX)

Nasdaq · Westbrook, Maine, USA · Founded 1983 · CEO Jonathan Mazelsky

Valuation summary

$268.00 fair value versus $689.65 in the market, a difference of -61.1%. Rated Sell.

Fair value per share$268.00
Current share price$689.65
Upside / downside-61.1%
Bear case$172.64
Bull case$405.00
Discount rate (WACC)8.9%
Terminal growth2.80%
Market capitalisation$54B
EV / Sales12.0x

About IDEXX Laboratories, Inc.

Founded in 1983. IDEXX makes veterinary diagnostic equipment and the test consumables that run on it, plus practice management software for animal clinics. The model mirrors razor-and-blades: place an analyser in a veterinary practice, then sell the proprietary test slides it consumes for years afterwards. It holds a dominant position in companion animal diagnostics.

Investment case

  • Installed analysers lock in years of high-margin consumable revenue.
  • Pet healthcare spending has proved resilient through economic cycles.
  • Diagnostic testing rates per veterinary visit continue to rise.

Key risks

  • Veterinary clinic visit volumes have softened as pandemic-era pet adoption normalises.
  • Persistently expensive relative to almost any comparable business.
  • Veterinary staffing shortages constrain how many appointments clinics can run.

Recent developments

Revenue by segment

Companion Animal Diagnostics87%
Water Testing7%
Livestock & Other6%

Five-year forecast

RevenueFree cash flow
Year 1$5.2B$1.0B
Year 2$5.8B$1.1B
Year 3$6.4B$1.2B
Year 4$7.0B$1.3B
Year 5$7.7B$1.4B

What the street says

Regarded as an exceptional business model. The entire discussion is valuation and clinic visit trends. Second-quarter 2026 results, with 9% organic revenue growth and a full-year EPS outlook raised to $14.69–$14.94, kept the operating record intact.

Comparable companies: A · EW · RMD · ABT · SNY · DXCM · MDT · SYK

Open the interactive model, price chart and sensitivity grid →